All News

Growing cannabis, both indoors or outdoors, impacts the environment in several significant ways and one challenge of today’s cultivators is to consider how to lessen the negative effects of overwatering, pesticides, energy usage, and plastic pollution.

In today’s “In the News” New York takes center stage with cannabis topics ranging from delaying plans to offer cannabis farmers markets this summer and approving cannabis pop-up stores to establishing THC limits on hemp-derived cannabis products. Read the stories below!

Pharmaceutical developer Oxford Cannabinoid Technologies recently described the potential of its latest cannabinoid-based immunotherapy treatment.

Cannabis companies in Nevada urged for changes to their state’s adult-use and medical cannabis programs which were acknowledged through several passed legislations.

With federal legalization still hanging in the balance, cannabis is being legalized state-by-state. Each new setting that accepts cannabis forms their own rules and regulations which are not uniformed and could pose a danger. This has led to the phenomenon called “lab shopping”.

Growing trend in drug testing: more employers are changing their drug testing policies around cannabis.

A woman residing in Washington, D.C. sued her neighbor, claiming that their cannabis odor was a nuisance and affected her health.

Perzimmon #2 Live Dried flower from Industry Processing Solutions receives top honor at the Emerald Cup in the “Innovative Product: Consumable” category.

A House committee would like federal officials to dedicate research to create hemp-based plastic alternatives and to develop equipment which could be used to detect cannabis-impaired driving.

Cannabis Science and Technology® is pleased to announce the addition of Dominika Gruszecka to its editorial advisory board.

Near the end of June 2023, Luxembourg joined other countries in legalizing adult-use cannabis.

Our sister publication, Oncology Nursing News, interviewed two authors of a recent survey presented to nurses in California who worked with patients who used medical cannabis.

Our 2023 Providence show will feature expert-led cannabis science education and insights, presentations and networking opportunities

Our sister publication, Nutritional Outlook, recently published an article about market researchers BDSA and MSA and how they will provide cross-analysis of BDSA’s cannabis industry data, as well as, MSA’s CPG and healthcare data.

All THC-containing products must be sold exclusively at licensed dispensaries only.

Creators of Zkittlez, a popular cannabis strain, lost a lawsuit that prevents them from using the “Skittles” brand name on their products.

Our sister publication, CURE, recently spoke with Kim Stuck, breast cancer survivor and author of our blog Stuck on Compliance.

A recently published study compared various methods and associated costs of treating difficult-to-treat depression.

Recreational cannabis was approved in the state in June 2021, sales began at the beginning of 2023, and medical cannabis has been legal since 2012.

Recent activity in the Senate focuses on both recreational and medical cannabis regulations and reforms.

Long Island opened up its first recreational dispensary.

The FDA and FTC have sent warnings to several companies that market delta-8 THC edibles.

A randomized controlled trial examined the experiences of people with alcohol use disorder after being treated with psilocybin.

Our sister publication, dvm360, recently published an article discussing a study that was funded by the Morris Animal Foundation and was conducted by veterinary research team at the University of Saskatchewan located in Saskatoon, Saskatchewan, Canada.

Citing a growing interest in bio-based replacements for plastic, one study tested the addition of hemp to other bio-based materials.

Canadian government officials are being urged to allow First Nations peoples the ability to regulate their own cannabis production and sales.

A reportedly first-of-its-kind study tested the idea that cannabis use leads to other substance use in young adults.

Toms Shoes founder promises $100 million towards psychedelic research and access.